Accessibility Tools

Prescribing Information & Guidance


SGLT2 Inhibitors in Chronic Kidney Disease (CKD) in Adults


Prescribing Support Information for Primary Care

Approved by BLMK APC Feb 2024

View Document

Guideline Categories: Endocrinology and Diabetes

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: Canagliflozin, dapagliflozin, empagliflozin, SGLT2 inhibitors

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net